Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
TRIM54 |
Gene ID: |
57159 |
Uniprot ID: |
TRI54_HUMAN |
Immunogen Region: |
179-358 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 179-358 of human TRIM54 (NP_912730.2). |
Immunogen Sequence: |
AMLVAGNDRVQAVITQMEEV CQTIEDNSRRQKQLLNQRFE SLCAVLEERKGELLQALARE QEEKLQRVRGLIRQYGDHLE ASSKLVESAIQSMEEPQMAL YLQQAKELINKVGAMSKVEL AGRPEPGYESMEQFTVRVEH VAEMLRTIDFQPGASGEEEE VAPDGEEGSAGPEEERPDGP |
Tissue Specificity | Specifically expressed in heart and skeletal muscle. |
Function | May bind and stabilize microtubules during myotubes formation. |
Protein Name | Tripartite Motif-Containing Protein 54Muscle-Specific Ring Finger ProteinMurfMuscle-Specific Ring Finger Protein 3Murf-3Murf3Ring Finger Protein 30 |
Cellular Localisation | CytoplasmCytoskeletonMyofibrilSarcomereZ LineAssociates With MicrotubulesLocalizes To The Z-Lines In Skeletal Muscles |
Alternative Antibody Names | Anti-Tripartite Motif-Containing Protein 54 antibodyAnti-Muscle-Specific Ring Finger Protein antibodyAnti-Murf antibodyAnti-Muscle-Specific Ring Finger Protein 3 antibodyAnti-Murf-3 antibodyAnti-Murf3 antibodyAnti-Ring Finger Protein 30 antibodyAnti-TRIM54 antibodyAnti-MURF antibodyAnti-MURF3 antibodyAnti-RNF30 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance